Monoclonal Antibodies for Study of Antigenic Variation in Coxsackievirus Type B4: Association of Antigenic Determinants with Myocarditic Properties of the Virus Free

Abstract

SUMMARY

Monoclonal antibodies were produced to a field strain (Mil) of group B coxsackievirus type 4 (CBV-4), and to the prototype JVB strain. Nine were neutralizing antibodies and four were non-neutralizing antibodies with virus-specific activity in indirect immunofluorescence (IF) staining. On the basis of reactivity with the panel of monoclonal antibodies, nine different strains of CBV-4 were found to fall into five distinct antigenic groups. Antigenic variants were produced by using the neutralizing monoclonal antibodies to select variants from the Mil virus stock which were no longer susceptible to the selecting antibody. A high frequency of antigenic variation was seen. By using the variants in cross-neutralization and IF tests with the monoclonal antibodies, it was possible to identify five tentative antigenic sites functional in neutralization; one site appeared to be complex and possibly to consist of overlapping epitopes. Reactivity of the monoclonal antibodies was similar, but not necessarily identical, by neutralization and by IF staining. The antigenic variants were found to differ from the parent Mil strain, and from one another, in their myocarditic and cardiotropic properties in a murine model. Two of the variants produced more extensive cardiac pathology, and two produced higher virus titres in the heart than was produced by the parent strain. One variant was notable for extensive production of necrotic lesions in the myocardium. Four of the variants showed less histopathology and three produced less virus in the heart than was produced by the parent strain.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-5-925
1984-05-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/5/JV0650050925.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-5-925&mimeType=html&fmt=ahah

References

  1. Brown F., Wild T. F., Rowe L. W., Underwood B. O., Harris T. J. R. 1976; Comparison of swine vesicular disease virus and Coxsackie B5 virus by serological and RNA hybridization methods. Journal of General Virology 31:231–237
    [Google Scholar]
  2. Cao Y., Schnurr D. P., Schmidt N. J. 1984; Differing cardiotropic and myocarditic properties of group B type 4 coxsackievirus strains. Archives of Virology (in press)
    [Google Scholar]
  3. Choppin P. W., Eggers H. J. 1962; Heterogeneity of Coxsackie B4 virus: two kinds of particles which differ in antibody sensitivity, growth rate, and plaque size. Virology 18:470–476
    [Google Scholar]
  4. Emini E. A., Kao S.-Y., Lewis A. J., Crainic R., Wimmer E. 1983; Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. Journal of Virology 46:466–474
    [Google Scholar]
  5. Forghani B., Myoraku C. K., Schmidt N. J. 1982; Production of monoclonal antibodies to human IgM for assay of viral IgM antibodies. Journal of Virological Methods 5:317–327
    [Google Scholar]
  6. Graves J. H. 1973; Serological relationship of swine vesicular disease virus and Coxsackie B5 virus. Nature, London 245:314–315
    [Google Scholar]
  7. Hartig P. C., Madge G. E., Webb S. R. 1983; Diversity within a human isolate of Coxsackie B4: relationship to viral-induced diabetes. Journal of Medical Virology 11:23–30
    [Google Scholar]
  8. Oi V. T., Herzenberg L. A. 1980; Immunoglobulin-producing hybrid cell lines. In Selected Methods in Cellular Immunology pp 351–372 Edited by Mishell B. B., Shiigi S. S. San Francisco: W,. H. Freeman and Co;
    [Google Scholar]
  9. Prabhakar B. S., Haspel M. V., McClintock P. R., Notkins A. L. 1982; High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies. Nature, London 300:374–376
    [Google Scholar]
  10. Richter F. A., Macpherson L. W., Campbell J. B., Labzoffsky N. A. 1972; Studies on intratypic variants of Coxsackie B1 virus. Archiv für die gesamte Virusforschung 38:77–84
    [Google Scholar]
  11. Riggs I. L. 1979; Immunofluorescent staining. In Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections 5th edn., pp 141–151 Edited by Lennette E. H., Schmidt N. J. Washington, D,. C.: American Public Health Association;
    [Google Scholar]
  12. Schmidt N. J. 1979; Cell culture techniques for diagnostic virology. In Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections 5th edn., pp 65–139 Edited by Lennette E. H., Schmidt N. J. Washington, D,. C.: American Public Health Association;
    [Google Scholar]
  13. Wigand R., Sabin A. B. 1962; Intratypic antigenic heterogeneity of Coxsackie B viruses. Archiv fur die gesamte Virusforschung 12:29–41
    [Google Scholar]
  14. Yoon J. W., Austin M., Onodera T., Notkins A. L. 1979; Virus-induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. New England Journal of Medicine 300:1173–1179
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-5-925
Loading
/content/journal/jgv/10.1099/0022-1317-65-5-925
Loading

Data & Media loading...

Most cited Most Cited RSS feed